LakeShore Biopharma Co Net Income
| LSBCF Stock | 0.13 0.03 18.75% |
As of the 13th of February 2026, LakeShore Biopharma secures the Mean Deviation of 4.24, standard deviation of 9.31, and Risk Adjusted Performance of (0.18). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of LakeShore Biopharma, as well as the relationship between them. Please verify LakeShore Biopharma variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if LakeShore Biopharma Co is priced some-what accurately, providing market reflects its recent price of 0.13 per share. As LakeShore Biopharma appears to be a penny stock we also strongly suggest to check its jensen alpha numbers.
LakeShore Biopharma Total Revenue |
|
| Last Reported | Projected for Next Year | ||
| Net Loss | -90 M | -94.5 M | |
| Net Loss | -90 M | -94.5 M | |
| Net Loss | (0.84) | (0.88) | |
| Net Income Per E B T | 1.14 | 0.99 |
LakeShore | Net Income | Build AI portfolio with LakeShore Stock |
The Net Income trend for LakeShore Biopharma Co offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether LakeShore Biopharma is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest LakeShore Biopharma's Net Income Growth Pattern
Below is the plot of the Net Income of LakeShore Biopharma Co over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in LakeShore Biopharma financial statement analysis. It represents the amount of money remaining after all of LakeShore Biopharma Co operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is LakeShore Biopharma's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LakeShore Biopharma's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (99.98 M) | 10 Years Trend |
|
Net Income |
| Timeline |
LakeShore Net Income Regression Statistics
| Arithmetic Mean | (188,832,320) | |
| Coefficient Of Variation | (39.87) | |
| Mean Deviation | 38,282,365 | |
| Median | (191,826,242) | |
| Standard Deviation | 75,282,086 | |
| Sample Variance | 5667.4T | |
| Range | 343.5M | |
| R-Value | 0.15 | |
| Mean Square Error | 5917.1T | |
| R-Squared | 0.02 | |
| Significance | 0.58 | |
| Slope | 2,170,033 | |
| Total Sum of Squares | 90678.3T |
LakeShore Net Income History
Other Fundumenentals of LakeShore Biopharma
LakeShore Biopharma Net Income component correlations
LakeShore Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for LakeShore Biopharma is extremely important. It helps to project a fair market value of LakeShore Stock properly, considering its historical fundamentals such as Net Income. Since LakeShore Biopharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of LakeShore Biopharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of LakeShore Biopharma's interrelated accounts and indicators.
Click cells to compare fundamentals
Can Biotechnology industry sustain growth momentum? Does LakeShore have expansion opportunities? Factors like these will boost the valuation of LakeShore Biopharma. Expected growth trajectory for LakeShore significantly influences the price investors are willing to assign. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating LakeShore Biopharma demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Understanding LakeShore Biopharma requires distinguishing between market price and book value, where the latter reflects LakeShore's accounting equity. The concept of intrinsic value - what LakeShore Biopharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push LakeShore Biopharma's price substantially above or below its fundamental value.
Understanding that LakeShore Biopharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether LakeShore Biopharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, LakeShore Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
LakeShore Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to LakeShore Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of LakeShore Biopharma.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in LakeShore Biopharma on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding LakeShore Biopharma Co or generate 0.0% return on investment in LakeShore Biopharma over 90 days. LakeShore Biopharma is entity of United States More
LakeShore Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure LakeShore Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess LakeShore Biopharma Co upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.24) | |||
| Maximum Drawdown | 56.56 | |||
| Value At Risk | (18.75) | |||
| Potential Upside | 2.41 |
LakeShore Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for LakeShore Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as LakeShore Biopharma's standard deviation. In reality, there are many statistical measures that can use LakeShore Biopharma historical prices to predict the future LakeShore Biopharma's volatility.| Risk Adjusted Performance | (0.18) | |||
| Jensen Alpha | (1.99) | |||
| Total Risk Alpha | (2.96) | |||
| Treynor Ratio | 0.9368 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LakeShore Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
LakeShore Biopharma February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.18) | |||
| Market Risk Adjusted Performance | 0.9468 | |||
| Mean Deviation | 4.24 | |||
| Coefficient Of Variation | (435.43) | |||
| Standard Deviation | 9.31 | |||
| Variance | 86.73 | |||
| Information Ratio | (0.24) | |||
| Jensen Alpha | (1.99) | |||
| Total Risk Alpha | (2.96) | |||
| Treynor Ratio | 0.9368 | |||
| Maximum Drawdown | 56.56 | |||
| Value At Risk | (18.75) | |||
| Potential Upside | 2.41 | |||
| Skewness | (4.28) | |||
| Kurtosis | 18.5 |
LakeShore Biopharma Backtested Returns
LakeShore Biopharma has Sharpe Ratio of -0.25, which conveys that the firm had a -0.25 % return per unit of risk over the last 3 months. LakeShore Biopharma exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify LakeShore Biopharma's Mean Deviation of 4.24, risk adjusted performance of (0.18), and Standard Deviation of 9.31 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -2.29, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning LakeShore Biopharma are expected to decrease by larger amounts. On the other hand, during market turmoil, LakeShore Biopharma is expected to outperform it. At this point, LakeShore Biopharma has a negative expected return of -2.42%. Please make sure to verify LakeShore Biopharma's total risk alpha and the relationship between the skewness and period momentum indicator , to decide if LakeShore Biopharma performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.18 |
Insignificant reverse predictability
LakeShore Biopharma Co has insignificant reverse predictability. Overlapping area represents the amount of predictability between LakeShore Biopharma time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of LakeShore Biopharma price movement. The serial correlation of -0.18 indicates that over 18.0% of current LakeShore Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.18 | |
| Spearman Rank Test | 0.37 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
LakeShore Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, LakeShore Biopharma Co reported net income of (99.98 Million). This is 129.3% lower than that of the Healthcare sector and 242.74% lower than that of the Biotechnology industry. The net income for all United States stocks is 117.51% higher than that of the company.
LakeShore Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LakeShore Biopharma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LakeShore Biopharma could also be used in its relative valuation, which is a method of valuing LakeShore Biopharma by comparing valuation metrics of similar companies.LakeShore Biopharma is currently under evaluation in net income category among its peers.
LakeShore Fundamentals
| Revenue | 614.96 M | ||||
| EBITDA | (48.54 M) | ||||
| Net Income | (99.98 M) | ||||
| Total Debt | 414.4 M | ||||
| Cash Flow From Operations | (120.98 M) | ||||
| Number Of Employees | 758 | ||||
| Total Asset | 1.37 B | ||||
| Retained Earnings | (2.41 B) | ||||
| Working Capital | 17.47 M | ||||
| Net Asset | 1.37 B |
About LakeShore Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LakeShore Biopharma Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LakeShore Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LakeShore Biopharma Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Can Biotechnology industry sustain growth momentum? Does LakeShore have expansion opportunities? Factors like these will boost the valuation of LakeShore Biopharma. Expected growth trajectory for LakeShore significantly influences the price investors are willing to assign. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating LakeShore Biopharma demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Understanding LakeShore Biopharma requires distinguishing between market price and book value, where the latter reflects LakeShore's accounting equity. The concept of intrinsic value - what LakeShore Biopharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push LakeShore Biopharma's price substantially above or below its fundamental value.
Understanding that LakeShore Biopharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether LakeShore Biopharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, LakeShore Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.